Mar 01, 2021 / 09:00PM GMT
Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Hi, everyone. Welcome to the Cowen Healthcare Conference 2021 Fireside Chat with Sage. With us today from Sage is the new CEO, Barry Greene. Barry, thank you for -- thank you for joining us today.
Questions and Answers:
Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology AnalystI'm going to -- I'm just going to kick it off with a strategy question, and you can take this opportunity to elaborate a little bit if you want, if you think that there's something not covered in our discussion outline, but I'm sure you've gotten this question a number of times for the last couple of months.
Why Sage? I mean I've heard from third parties that your phone was ringing off the hook the second, your your planned move from Alnylam was announced. So what did you see in this opportunity, not just as a Board member, which was the original plan, but in the CEO role. What withdrew to Sage at a time where it was
Trustpilot
